
Wednesday, October 30, 2024 7:22:11 PM
Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200
https://www.biofrontera-us.com/research/product-pipeline
https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035
https://us.ameluz.com/
$GLYC

Recent GLYC News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 11:38:34 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/14/2025 09:35:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:35:12 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/13/2025 09:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 10:00:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/13/2025 02:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 02:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:30:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/27/2024 07:22:44 PM
- Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 • PR Newswire (US) • 11/12/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 09:47:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:42:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/06/2024 10:41:38 PM
- GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting • Business Wire • 11/06/2024 12:00:00 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 11/04/2024 09:26:15 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/04/2024 07:01:21 PM
- Biotech Up Over +100% Premarket Following Merger And Funding Announcement • AllPennyStocks.com • 10/29/2024 02:00:00 PM
- Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement • AllPennyStocks.com • 10/29/2024 02:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/29/2024 12:09:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:09:13 PM
- GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma • Business Wire • 10/29/2024 11:00:00 AM
- GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint • Business Wire • 10/29/2024 10:30:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/15/2024 09:01:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:00:35 PM
YCRM ReachOut Technology Returns to Trading: CEO Rick Jordan Lays Out Blockchain CyberSecurity Strategy and Industry-First AI MSP Partnership In Shareholder Letter • YCRM • Feb 18, 2025 11:20 AM
VAYK Confirms No Dilution Following Recent Acquisition and 11 Million Insider Purchase • VAYK • Feb 18, 2025 9:30 AM
UAV Corp. (OTC: UMAV) Announces Nationwide Teleconference to Provide Shareholders with Key Updates on Contracts, Future Plans, and Share Structure • UMAV • Feb 18, 2025 8:30 AM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM